Allyson Whyte Nowak

PartnerNorton Rose Fulbright Canada LLPIntellectual Property & Technology; Commercial; In-House Counsel; Litigation and Dispute Resolution

Allyson Whyte Nowak practices intellectual property and related litigation, including patent litigation relating to financial services, life and health sciences (pharmaceutical compounds, biotechnology, and medical devices), as well as litigation related to trade secrets and confidential information, copyright, trade-marks and trade libel. She has tremendous experience in damages actions under the Patented Medicines (Notice of Compliance) Regulations. Ms. Whyte Nowak's solicitor work includes freedom to operate, validity and infringement opinions, as well as advice in connection with the protection of trade secrets, including non-disclosure and confidentiality agreements and non-competition agreements.

Allyson Whyte Nowak was called to the Ontario Bar in 1996 after obtaining her LL.B and B.C.L. degrees from McGill University in 1994 (with Distinction).

Her practice focuses on intellectual property and related litigation, including patent litigation relating to financial services, life and health sciences (pharmaceutical compounds, biotechnology, and medical devices), as well as litigation related to trade secrets and confidential information, copyright, trade-marks and trade libel. With significant trial and appellate experience, Ms. Whyte Nowak also has particular expertise in damages actions under the Patented Medicines (Notice of Compliance) Regulations.

Ms. Whyte Nowak's solicitor work includes freedom to operate, validity and infringement opinions, as well as advice in connection with the protection of trade secrets, including non-disclosure and confidentiality agreements and non-competition agreements.

Ms. Whyte Nowak has published a variety of articles on intellectual property-related issues and has been a guest lecturer at the University of Toronto, Osgoode and University of Victoria law schools on topics including: the conduct of a patent trial; trade secrets Pharma and Biotech Litigation and privacy law.

Education

  • McGill University, LL.B., B.C.L., 1994

Bar Admission

  • Ontario, 1996

Experience

  • Apotex Inc. v. Merck Canada Inc. 2012 FC 1235
  • Amazon.com, Inc. v. Canada (Attorney General) (2011), 97 C.P.R. (4th) 171 (F.C.A.)
  • Tajdin v. Aga Khan (2011), 93 C.P.R. (4th) 411 (F.C.A.)
  • DataTreasury Corporation v. Royal Bank of Canada et al. (2011), 70 C.P.R. (4th) 241 (F.C.)
  • Apotex Inc. v. Wellcome Foundation Ltd. (2004), 31 C.P.R. (4th) 210 (F.C.A.)

Associations

  • Canadian Bar Association (CBA) (Intellectual Property Law Section)
  • Appointed representative of the CBA on the Intellectual Property User's Committeee, May 2011 to Present
  • Toronto Intellectual Property Group
  • The Advocates' Society

Awards & Honours

  • Best Lawyers in Canada, Intellectual Property Law, 2013